Breast Cancer Action (BCA) released a report today, in conjunction with a poster presentation at the San Antonio Breast Cancer Symposium, on the side effects of aromatase inhibitors (AIs). The report, “Side Effects Revealed: Women’s Experiences with Aromatase Inhibitors,” analyzes 612 women’s responses to an online survey of the drugs’ side effects.
Trust for America’s Health (TFAH) today commended the federal government’s progress in executing 92 percent of the six month benchmarks in the national pandemic preparedness implementation plan.
An emulsion of olive oil, egg yolk and glycerine might be just the recipe to keep heart patients away from the operating room and cardiac bypass surgery.
Neurobiologists have discovered why the aging brain produces progressively fewer new nerve cells in its learning and memory center. The scientists said the finding, made in rodents, refutes current ideas on how long crucial “progenitor” stem cells persist in the aging brain.
An enzyme found at elevated levels in several human cancers has been linked to abnormal tumor growth in fruit flies, a discovery that provides a new model for understanding the link between stem cell biology and cancer, according to researchers at the University of Oregon.
Scientists are reporting discovery of technology that may simplify construction of those much-discussed Micro Total Analysis Systems (micro-TASs) ? “labs-on-a-chip” with whole medical and scientific laboratories shrunk to the size of computer chips.
Almost four in five Australians (78 percent) support mandatory fitness testing for school children to combat childhood obesity, according to a new public opinion poll by Research Australia.
With holiday celebrations to attend and family gatherings to prepare for, the winter season can be busy and joyful. But for many, heightened expectations and the stresses of holiday events can increase anxiety and cause depression.
The UCLA Department of Family Medicine, under the direction of Principal Investigator Michael A. Rodriguez, MD, MPH, is receiving a two-year, $300,000 grant from Finding Answers: Disparities Research for Change, a National Program Office of the Robert Wood Johnson Foundation (RWJF) housed at the University of Chicago that evaluates interventions aimed at eliminating racial and ethnic health care disparities in local communities.
Biophan Technologies, Inc., a developer of next-generation medical technology, in conjunction with MYOTECH, LLC, recently presented results of animal studies that indicate the potential of the MYO-VAD, a cardiac support system to significantly improve the treatment of heart failure. The MYO-VAD restores cardiac output on an arrested or weak heart. The device can be implanted in approximately three minutes.